Martin Wax und Ophthalmology - Info zur Person

(1 - 10 von 11

)

Dharmacon und Alcon werden bei der Entdeckung neuer, RNAi-basierter...

www.finanznachrichten.de

auszulÃƒÂ¶sen", sagte Dr. Martin Wax, Vize-PrÃƒÂ¤sident von Research and Development und Direktor von Ophthalmology Discovery Research bei ...

Increased Incidence of Paraproteinemia and Autoantibodies in Patients...

www.sciencedirect.com

Reprint requests to Martin Wax, M.D., Department of Ophthalmology and Visual Science, Box 8096, 660 S. Euclid Ave., St. Louis, MO

Dr. Martin B Wax - New York NY, Ophthalmology, 111 Broadwaywww.healthcare6.com › ... › New York › New York

www.healthcare6.com

Dr. Martin B Wax - New York NY, Ophthalmology at 111 Broadway. Phone: (212) View info, ratings, reviews, specialties, education history, and more.

Dr. Martin B Wax, Ophthalmology, Dallas TX

www.topnpi.com

Dr. Martin B Wax in Dallas, TX. Dr. Martin B Wax, MD specializes in ophthalmology, practices at Harry Hines Boulevard, phone number, opening hours, doctor...

Dr. Martin Wax, MD – New York, NY | Ophthalmology

www.doximity.com

Martin B. Wax M.D. is currently the Chief Medical Officer and Executive Vice-President of R&D at PanOptica, Inc., a private biotechnology company specializing ...

Martin B. Wax, MD - Ophthalmologist in Dallas, TXwww.md.com › ... › Texas › Dallas

www.md.com

Martin Wax is an ophthalmologist in Dallas. As an eye doctor, he diagnoses and treats diseases, injuries, or trauma of the eye such as glaucoma or cataracts.Doctor Specialty: Ophthalmology Martin Wax is an ophthalmologist in Dallas. As an eye doctor, he diagnoses and treats diseases, injuries, or trauma of the eye such as glaucoma or cataracts. Doctor Specialty: Ophthalmology

PanOptica Anti-VEGF Eye Drop Shows Promise in Treatment of...

pipelinereview.com

The company was co-founded by Paul Chaney, past president of OSI-Eyetech, and Martin Wax, MD, a noted academic clinician scientist working in glaucoma, and most recently vice president of research and development and head of ophthalmology discovery and pre-clinical development at Alcon Labs, Inc.

PanOptica Reports Positive Results from Phase 1/2 Clinical ...

pipelinereview.com

The company was co-founded by Paul Chaney, past president of OSI-Eyetech and Martin Wax, MD, a noted academic clinician scientist working in glaucoma, and most recently VP of research and development and head of ophthalmology discovery and pre-clinical development at Alcon Labs, Inc.